Holographic display developer Voxel of Laguna Hills, CA, entered the arbitration process Dec. 10 in its dispute with former manufacturing partner General Scanning of Watertown, MA. Voxel is charging that Voxcam cameras produced by General Scanning were
Holographic display developer Voxel of Laguna Hills, CA, entered the arbitration process Dec. 10 in its dispute with former manufacturing partner General Scanning of Watertown, MA. Voxel is charging that Voxcam cameras produced by General Scanning were delivered late and did not meet the company's expectations (SCAN 1/22/97). The arbitration process will take place before a three-judge panel in Irvine, CA, and is expected to be concluded by January, according to Raymond Schulz, director of marketing at Voxel.
In the meantime, Voxel is building a capacity to take components manufactured by subcontractors and integrate them in-house, and the company should be ready to make production shipments by September 1998, Schulz said. Until then, Voxel is pursuing letters of intent with interested parties, and has eight to 12 commitments in line.
Voxel also reinstalled a beta Voxcam unit at the Department of Veterans Affairs Joint Imaging Service at the New Mexico Regional Federal Medical Center. The unit had originally been manufactured by General Scanning, but was pulled from the site due to performance problems. Voxel reports that since the installation the Voxcam has been used to produce images that have been express-delivered to sites around the U.S., where they have been read on special Voxel light boxes.
In other Voxel news, at this month's Radiological Society of North America meeting the company presented two papers on its technology: one a comparison of holography of neurovascular pathology with surface renderings, and the other on holography of spines containing metal hardware. The company also showcased Voxplan, a new software package that approximates on a computer what a Voxgram will look like prior to its production. Voxel anticipates that technologists setting up holograms will use Voxplan, Schulz said.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).